Precision Neuroscience Secures FDA Approval for Breakthrough Brain-Computer Interface

In a significant milestone for medical technology, Precision Neuroscience has received clearance from the U.S. Food and Drug Administration (FDA) for its innovative brain-computer interface device. This groundbreaking advancement positions the company as a strong contender in the rapidly evolving field of neurotechnology, paralleling efforts and innovations by the renowned Neuralink.

Continue reading